H

Active Director Whole-Time Director DIN 09517518
DIN 09517518 First appointment Mar 2022 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Harsha

Data last updated:

Harsha is a Whole-Time Director at Ammana Bio Pharma Limited (since 2022). The company operates in Chemicals and Materials.

DIN 09517518
Primary Designation Whole-Time Director
Industry Chemicals and Materials
First Appointment 26 Mar 2022
Oldest Company Age 31 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ammana Bio Pharma Limited U92490AP1994PLC018659
Whole-Time Director26 Mar 20221994Active

Board colleagues of Harsha

NameDINCompanyDesignation
Rajaram Bendone Jayaram06785128Ammana Bio Pharma LimitedDirector
Varun Bendone Jayaram09479102Ammana Bio Pharma LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Ammana Bio Pharma Limited
Premium access

Shareholding and investment profile for Harsha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harsha

Harsha currently holds 1 directorship: Ammana Bio Pharma Limited (Whole-Time Director, since 26 Mar 2022).

Harsha was first appointed on 26 Mar 2022 as Whole-Time Director at Ammana Bio Pharma Limited.

The current boards of Harsha's companies include Rajaram Bendone Jayaram (Ammana Bio Pharma Limited), Varun Bendone Jayaram (Ammana Bio Pharma Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available